Dongyoun Deborah Lee, M.D.
Medical Oncology Physician · Pennington, NJ
Dongyoun Deborah Lee, M.D. is a medical oncology physician with a practice address in Pennington, New Jersey, and NPI 1073919312, issued on Nov 14, 2014. Check the license (New Jersey 25MA09947600, as entered in NPPES) on the New Jersey State Board of Medical Examiners; the Medicare figures below come from public CMS files.
- Name
- Dongyoun Deborah Lee
- Credential
- M.D.
- Primary taxonomy
- Medical Oncology Physician 207RX0202X
- License number
- 25MA09947600 NJ
Self-reported in NPPES; status is on the state search - Practice location
- 2 Capital Way Ste 220, Pennington, NJ 08534
- Phone
- (609) 303-0747
- Enumerated
- Nov 14, 2014
- Record last updated
- Feb 18, 2020 (not updated in 6 years: call before relying on the address or phone)
- Medicaid ID
- 3046303 NJ
- Medicare enrollment
- Enrolled (PECOS I20250711002559); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 2 Capital Way Ste 220
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Shajla Ajas, MDHematology & Oncology Physician1598241747
- Rakesh Biswas, MDHematology & Oncology Physician1679003487
- Pamela Crilley, DOHematology & Oncology Physician1538116041
- Peter Graham, MDMedical Oncology Physician1841385226
- Jennifer Hong, MDHematology & Oncology Physician1619400280
- Hongyan Liang, MDHematology & Oncology Physician1194931568
Verify Dongyoun Deborah Lee in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersNew Jersey State Board of Medical Examiners
Search for license 25MA09947600Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
2% fewer Medicare Part D claims than the average medical oncology physician in 2024
687 Medicare Part D claims for 134 beneficiaries, against an average of 703 among the 4,230 providers of this specialty who prescribed in Part D. Brand-name drugs were 35% of claims. 61 claims were for opioids.
Most prescribed
- Eliquis107 claims
- Anastrozole105 claims
- Xarelto28 claims
- Hydroxyurea21 claims
- Gabapentin20 claims
- Ondansetron Hcl19 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 95.8 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $547.80
29 payments; by number, the most common kind was food and beverage; the largest payer was Novartis Pharmaceuticals Corporation. The 3,343 providers of this specialty with any payment received $11,773.47 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- University Primary Care Practices IncCleveland, OH
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Medical Oncology Physician providers in New Jersey
There are 140 medical oncology physician records in New Jersey.
Other medical oncology physician records in New Jersey
- Peter Abdelmessieh, DORobbinsville, NJ1073803896
- Prashasti Agrawal, MDMiddletown, NJ1720540495
- Joseph AisnerNew Brunswick, NJ1649328410
- Robert Alter, MDHackensack, NJ1306805460
- Sunny Arora, MDWest Long Branch, NJ1467959338
- Brooke BarberHammonton, NJ1043137755
- Neel Belani, MDEast Brunswick, NJ1982196937
- Noa Biran, M.D.Hackensack, NJ1023277910
- Patrick Boland, MDNew Brunswick, NJ1982870333
- Andrew Brown, M.D.Livingston, NJ1386800464
Common questions
What is Dongyoun Deborah Lee, M.D.'s NPI number?
Dongyoun Deborah Lee, M.D.'s National Provider Identifier (NPI) is 1073919312, issued on Nov 14, 2014. An NPI identifies a provider in billing; it is not a license.
Where is Dongyoun Deborah Lee, M.D. located?
The NPPES record lists a practice address at 2 Capital Way Ste 220, Pennington, NJ, 08534. Phone: (609) 303-0747. Providers update this record themselves, so call before visiting.
How can I verify Dongyoun Deborah Lee, M.D.'s license?
NPPES lists New Jersey license number 25MA09947600, as entered by the provider. Search the New Jersey State Board of Medical Examiners at https://newjersey.mylicense.com/verification/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Dongyoun Deborah Lee, M.D. prescribe under Medicare Part D?
In 2024, Dongyoun Deborah Lee, M.D. had 687 Medicare Part D claims for 134 beneficiaries; the average among medical oncology physician prescribers was 703. Part D covers Medicare prescriptions only.
What is Dongyoun Deborah Lee, M.D.'s MIPS final score?
The 2023 MIPS final score is 95.8 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.